GeneDx Holdings Corp. — Director's Dealing 2021

Nov 3, 2021

SEC Form 4/A — Form 4/A

Issuer: Sema4 Holdings Corp. (SMFR)
CIK: 0001818331
Period of Report: 2021-10-01

Reporting Person: Assad Shawn (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-01	Restricted Stock Unit	$	A	34776	Acquired		Class A Common Stock (34776)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

F2: This Form 4 is being amended to correct the vesting schedule as to 25% of the total shares vest on October 1, 2023, and thereafter as to 75% of the total shares underlying the award in quarterly installments until fully vested on October 1, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.